LPCN 1144 Resolves NAFLD in Hypogonadal Males

por Albhaisi, Somaya, Kim, Kilyoung, Baker, Jonathan, Chidambaram, Nachiappan, Patel, Mahesh V., Charlton, Michael, Sanyal, Arun J.
Publicado 2020

A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism

por DelConte, Anthony, Papangkorn, Kongnara, Kim, Kilyoung, Bruno, Benjamin J., Chidambaram, Nachiappan, Khera, Mohit, Goldstein, Irwin, Kohler, Tobias S., Miner, Martin, Dobs, Adrian S., Patel, Mahesh V.
Publicado 2022

SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment

por DelConte, Anthony, Patel, Mahesh V, Papangkorn, Kongnara, Chidambaram, Nachiappan, Bruno, Benjamin J, Kim, Kilyoung, Frank, Joel, Khera, Mohit, Miner, Martin, Kaminetsky, Jed, Vignozzi, Linda, Goldstein, Irwin
Publicado 2020

TLANDO, a Novel Oral TRT, Improves Sexual and Mental Domain Outcomes in Hypogonadal Men

por Bruno, Benjamin J, Vangara, Kiran, Kim, Kilyoung, Papangkorn, Kongnara, Chidambaram, Nachiappan, Patel, Mahesh V, DelConte, Anthony, Carson III, Culley C, Goldstein, Irwin, Kaminetsky, Jed, Miner, Martin, Khera, Mohit
Publicado 2021